Status: current, Primitive. Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3727208013 | Lanadelumab (substance) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3727209017 | Lanadelumab | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Lanadelumab | Is a | Enzyme inhibitor | false | Inferred relationship | Some | ||
| Lanadelumab | Is a | Kallikrein inhibitor | true | Inferred relationship | Some | ||
| Lanadelumab | Has disposition | Kallikrein inhibitor | true | Inferred relationship | Some | ||
| Lanadelumab | Is a | Monoclonal antibody | true | Inferred relationship | Some | ||
| Lanadelumab | Is a | Enzyme inhibitor protein | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Lanadelumab-containing product | Has active ingredient | True | Lanadelumab | Inferred relationship | Some | 1 |
| Lanadelumab-containing product in parenteral dose form | Has active ingredient | True | Lanadelumab | Inferred relationship | Some | 1 |
| Lanadelumab only product | Has active ingredient | True | Lanadelumab | Inferred relationship | Some | 1 |
| Lanadelumab only product in parenteral dose form | Has active ingredient | True | Lanadelumab | Inferred relationship | Some | 1 |
| Lanadelumab 150 mg/mL solution for injection | Has precise active ingredient | True | Lanadelumab | Inferred relationship | Some | 1 |
| Lanadelumab 150 mg/mL solution for injection | Has BoSS | True | Lanadelumab | Inferred relationship | Some | 1 |
Reference Sets
Substance foundation reference set
FHIR